Evidence map›Paper›PMID 34667181›Full record

ArticleScientific reports2021

Altered protein O-GlcNAcylation in placentas from mothers with diabetes causes aberrant endocytosis in placental trophoblast cells.

Victoria Palin, Matthew Russell, Robert Graham, John D Aplin, Melissa Westwood

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Cells · 2023
    Review
  8. ProteinFrontiers in endocrinology · 2022
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Victoria PalinMaternal and Fetal Health Research Centre, University of Manchester, Manchester Academic Health Sciences Centre, Manchester, M13 9WL, UK.
Matthew RussellDivision of Molecular and Clinical Cancer Sciences, Stoller Biomarker Discovery Centre and Pathology Node, University of Manchester, Manchester, M13 9WL, UK.
Robert GrahamDivision of Molecular and Clinical Cancer Sciences, Stoller Biomarker Discovery Centre and Pathology Node, University of Manchester, Manchester, M13 9WL, UK.
John D AplinMaternal and Fetal Health Research Centre, University of Manchester, Manchester Academic Health Sciences Centre, Manchester, M13 9WL, UK.
Melissa WestwoodMaternal and Fetal Health Research Centre, University of Manchester, Manchester Academic Health Sciences Centre, Manchester, M13 9WL, UK. melissa.westwood@manchester.ac.uk.
University of Manchester · GBManchester Academic Health Science Centre · GBQueen's University Belfast · GBSt Mary's Hospital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Women with pre-existing diabetes have an increased risk of poor pregnancy outcomes, including disordered fetal growth, caused by changes to placental function. Here we investigate the possibility that the hexosamine biosynthetic pathway, which utilises cellular nutrients to regulate protein function via post-translationally modification with O-linked N-acetylglucosamine (GlcNAc), mediates the placental response to the maternal metabolic milieu. Mass spectrometry analysis revealed that the placental O-GlcNAcome is altered in women with type 1 (n = 6) or type 2 (n = 6) diabetes T2D (≥ twofold change in abundance in 162 and 165 GlcNAcylated proteins respectively compared to BMI-matched controls n = 11). Ingenuity pathway analysis indicated changes to clathrin-mediated endocytosis (CME) and CME-associated proteins, clathrin, Transferrin (TF), TF receptor and multiple Rabs, were identified as O-GlcNAcylation targets. Stimulating protein O-GlcNAcylation using glucosamine (2.5 mM) increased the rate of TF endocytosis by human placental cells (p = 0.02) and explants (p = 0.04). Differential GlcNAcylation of CME proteins suggests altered transfer of cargo by placentas of women with pre-gestational diabetes, which may contribute to alterations in fetal growth. The human placental O-GlcNAcome provides a resource to aid further investigation of molecular mechanisms governing placental nutrient sensing.

Indexed as

AcetylglucosamineAcylationAdultClathrinDiabetes MellitusEndocytosisFemaleGlycosylationHexosaminesHumansMothersN-AcetylglucosaminyltransferasesPlacentaPregnancyProtein Processing, Post-TranslationalTrophoblastsAcetylglucosamineClathrinHexosaminesN-Acetylglucosaminyltransferases

Identifiers

PMID34667181
PMCPMC8526670
OpenAlexW3205025684

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.